Crescent Biopharma, Inc. (CBIO)
18.51
+0.58
(+3.23%)
USD |
NASDAQ |
Sep 02, 16:00
18.51
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Total Liabilities (Quarterly) : 19.50M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 19.50M |
| March 31, 2026 | 15.28M |
| December 31, 2025 | 37.28M |
| September 30, 2025 | 21.63M |
| June 30, 2025 | 18.18M |
| March 31, 2025 | 2.617M |
| December 31, 2024 | 5.778M |
| September 30, 2024 | 4.322M |
| June 30, 2024 | 4.356M |
| March 31, 2024 | 5.294M |
| December 31, 2023 | 6.902M |
| September 30, 2023 | 6.653M |
| June 30, 2023 | 7.021M |
| March 31, 2023 | 6.740M |
| December 31, 2022 | 8.881M |
| September 30, 2022 | 7.844M |
| June 30, 2022 | 9.317M |
| March 31, 2022 | 13.43M |
| December 31, 2021 | 12.74M |
| September 30, 2021 | 11.38M |
| June 30, 2021 | 12.09M |
| March 31, 2021 | 12.90M |
| December 31, 2020 | 14.61M |
| September 30, 2020 | 12.15M |
| June 30, 2020 | 12.60M |
| Date | Value |
|---|---|
| March 31, 2020 | 13.61M |
| December 31, 2019 | 13.77M |
| September 30, 2019 | 13.37M |
| June 30, 2019 | 13.78M |
| March 31, 2019 | 11.65M |
| December 31, 2018 | 9.375M |
| September 30, 2018 | 7.074M |
| June 30, 2018 | 7.701M |
| March 31, 2018 | 9.382M |
| December 31, 2017 | 8.882M |
| September 30, 2017 | 7.258M |
| June 30, 2017 | 6.190M |
| March 31, 2017 | 5.288M |
| December 31, 2016 | 7.087M |
| September 30, 2016 | 6.259M |
| June 30, 2016 | 6.894M |
| March 31, 2016 | 5.934M |
| December 31, 2015 | 7.991M |
| September 30, 2015 | 7.037M |
| June 30, 2015 | 6.825M |
| March 31, 2015 | 4.104M |
| December 31, 2014 | 6.460M |
| September 30, 2014 | 4.723M |
| June 30, 2014 | 3.636M |
| March 31, 2014 | 2.71M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Encompass Health Corp. | 3.996B |
| Myriad Genetics, Inc. | 335.00M |
| BioRestorative Therapies, Inc. | 1.615M |
| U.S. Stem Cell, Inc. | -- |
| Marijuana, Inc. | 0.873M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 182.76M |
| Shareholders Equity (Quarterly) | 163.26M |
| Debt to Equity Ratio | 0.0088 |
| Current Ratio | 9.657 |
| Net Debt Paydown Yield | -0.06% |